Address

Novartis Venture Fund
100 Technology Square
Cambridge, MA 02139
United States

Open map

Novartis Venture Fund
c/o Novartis International AG
Postfach CH-4002
Basel
Switzerland

Open map

KANDO id: 42466

Corporate information

Also known as
Novartis Venture Fund
Registration country

Funding rounds

Investment preferences

Investment criteria
We are stage agnostic (seed to commercial companies) and invest in multiple therapeutic areas where there is clear unmet medical need. Our first step in the process is to review non-confidential information about the company, team, technology / data, financial and exit plan. The further evaluation of business proposals is then based on confidential presentations by the management team that starts the full due diligence process.

Investments by the Novartis Venture Fund are made as equity participation typically as the lead or co-lead investor in a syndicate with a board seat.
Investment focus themes
Top investment portfolio themes
healthcare (1)  

Actual initial investment stage
N/A (2)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 83
Profile Country Funding
Alios BioPharma Inc N/A
AMP Therapeutics GmbH N/A
Anchor Therapeutics Inc N/A
Atlas Genetics Ltd N/A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. N/A
Celladon Corp N/A
Cellerix SA Biotechnology company in the field of cell therapy, which is developing stem-cell based treatments for auto-immune diseases N/A
Cequent Pharmaceuticals N/A
CombinatoRx Inc Biopharmaceutical company. N/A
Covagen AG N/A
Cytos Biotechnology AG N/A
Destiny Pharma N/A
Diagnoplex Sarl N/A
EraGen Biosciences Inc N/A
ESBATech AG Switzerland based Biomedical Research Unit of Alcon N/A
Euthymics Bioscience Inc N/A
Evolva Holding SA N/A
Eyetech Pharmaceuticals Inc Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. N/A
FoldRx Pharmaceuticals Inc N/A
Forma Therapeutics Inc N/A
Genedata AG N/A
GlycArt Biotechnology AG N/A
GlycoMimetics Inc N/A
Heptares Therapeutics Ltd N/A
Idenix Pharmaceuticals Inc N/A

Past employees

Selected Products / Customers

Financials